About this document
Etanercept for Pediatric Plaque Psoriasis by Sitti Nurdiana Diauddin is a document available to read on EtoBox.
This document describes a study that assessed the efficacy and safety of the drug etanercept for treating moderate to severe plaque psoriasis in children and adolescents. The study was a randomized, double-blind, placebo-controlled trial involving over 100 patients ages 4 to 17 years old. Patients received either a dose of 0.8 mg/kg of etanercept or a placebo by subcutaneous injection once weekly for 12 weeks. Results showed that etanercept significantly reduced disease severity as measured by PASI scores a
- Author
- Sitti Nurdiana Diauddin
- Language
- EN